Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.38 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | FCER2 | P06734 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3658991 | 0.84 | MAOA (0.42) | NR1H2MAOACA2MAOBESR1 | |
| SCHEMBL30312969 | 0.83 | MAOA (0.66) | NR1H2MAOACA2MAOBTAAR1 | |
| SCHEMBL8656423 | 0.81 | MAOA (0.40) | NR1H2MAOACA2MAOBESR1 | |
| SCHEMBL15855667 | 0.79 | HPGD (0.49) | MAOAMAOBLMNAMAPTCYP2C19 | |
| SCHEMBL1549295 | 0.79 | BACE1 (0.51) | NR1H2MAOACA2BACE1TAAR1 | |
| SCHEMBL23393807 | 0.78 | MAOA (0.41) | MAOAMAOBMTNR1AMTNR1B | |
| SCHEMBL11396813 | 0.78 | MAOA (0.51) | NR1H2MAOACA2MAOBESR1 | |
| SCHEMBL3228855 | 0.78 | TAAR1 (0.50) | MAOAMAOBESR1ESR2BACE1 | |
| SCHEMBL8260518 | 0.77 | MAOA (0.48) | MAOAMAOBMTNR1AMTNR1BCYP3A4 | |
| SCHEMBL8258989 | 0.77 | HPGD (0.50) | MAOAMAOBLMNACYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1944305-B1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LTD (GB) | 2011-10-19 | — | — | EP | disclosed |
| US-7572915-B2 | 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; asthma, COPD, allergic rhinitis, or rheumatoid arthritis in a human | GLAXO GROUP LIMITED (GB) | 2009-08-11 | — | — | US | disclosed |
| US-7566786-B2 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2009-07-28 | — | — | US | disclosed |
| EP-1944305-A1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2008-07-16 | — | — | EP | disclosed |
| EP-1633748-B1 | QUINOLINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS | GLAXO GROUP LTD (GB) | 2008-03-05 | — | — | EP | disclosed |
| US-20070142373-A1 | Quinoline derivatives as phosphodiesterase inhibitors | GLAXO GROUP LIMITED (GB) | 2007-06-21 | — | — | US | disclosed |
| WO-2007064869-A2 | CATALYSTS FOR ARYL SULFIDE SYNTHESIS AND METHOD OF PRODUCING ARYL SULFIDES | YALE UNIVERSITY (US) | 2007-06-07 | — | — | WO | disclosed |
| US-20070049570-A1 | Quinoline derivatives as phosphodiesterase inhibitors | DEAN ANTHONY W | 2007-03-01 | — | — | US | disclosed |
| WO-2006102760-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2006-10-05 | — | — | WO | disclosed |
| US-20060178416-A1 | Quinoline derivatives as phosphodiesterase inhibitors | BARKER MICHAEL D | 2006-08-10 | — | — | US | disclosed |
| US-4405796-A | Processes for making phosphorus derivatives of aminothiomethylcarbamates | THE UPJOHN COMPANY (US) | 1983-09-20 | — | — | US | disclosed |
| US-4354975-A | Processes for making phosphorus derivatives of aminothiomethylcarbamates | THE UPJOHN COMPANY (US) | 1982-10-19 | — | — | US | disclosed |
| US-4336207-A | Phosphorus derivatives of aminothiocarbamoyl halides | THE UPJOHN COMPANY (US) | 1982-06-22 | — | — | US | disclosed |
| US-4308217-A | Disulfides of amides of phosphoric acid | THE UPJOHN COMPANY (US) | 1981-12-29 | — | — | US | disclosed |
| US-4279840-A | Processes for making phosphorus containing aminothiocarbamoyl halides | THE UPJOHN COMPANY (US) | 1981-07-21 | — | — | US | disclosed |
| US-4279839-A | Processes for making phosphorus containing aminothiocarbamoyl halides | THE UPJOHN COMPANY (US) | 1981-07-21 | — | — | US | disclosed |
| US-4234521-A | Phosphorus derivatives of aminothiocarbamoyl halides | THE UPJOHN COMPANY (US) | 1980-11-18 | — | — | US | disclosed |
| US-4208409-A | N-[(phosphinyl or phosphinothioyl)amino]thio-methylcarbamates and pesticidal methods | THE UPJOHN COMPANY (US) | 1980-06-17 | — | — | US | disclosed |
| US-4201733-A | PESTICIDES | THE UPJOHN COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
| US-4081536-A | N-[(phosphinyl) amino]thio- and N-[(phosphinothioyl)amino]-thio-methylcarbamates and methods for controlling insects | THE UPJOHN COMPANY (US) | 1978-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178416-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | NR1H2 1484/4885MAOA 106/4885CA2 1594/4885 |
| US-20070049570-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | NR1H2 1484/4885MAOA 106/4885CA2 1594/4885 |
| US-20070142373-A1 | Quinoline derivatives as phosphodiesterase inhibitors | PDE3B, PDE4B, PDE4A | NR1H2 1484/4885MAOA 106/4885CA2 1594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.